State Board of Administration of Florida Retirement System’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-7,855
Closed -$44K 2461
2016
Q1
$44K Hold
7,855
﹤0.01% 2386
2015
Q4
$135K Hold
7,855
﹤0.01% 2349
2015
Q3
$166K Hold
7,855
﹤0.01% 2294
2015
Q2
$389K Hold
7,855
﹤0.01% 2065
2015
Q1
$615K Buy
7,855
+28
+0.4% +$1.74K ﹤0.01% 1836
2014
Q4
$474K Hold
7,827
﹤0.01% 2022
2014
Q3
$333K Hold
7,827
﹤0.01% 2169
2014
Q2
$484K Buy
7,827
+24
+0.3% +$1.4K ﹤0.01% 2042
2014
Q1
$507K Hold
7,803
﹤0.01% 1975
2013
Q4
$439K Hold
7,803
﹤0.01% 2081
2013
Q3
$479K Hold
7,803
﹤0.01% 2017
2013
Q2
$456K Buy
+7,803
New +$480K ﹤0.01% 2034

Other funds holding OREX

State Board of Administration of Florida Retirement System's OREX Position: Q2 2016 in Review

State Board of Administration of Florida Retirement System sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2016, closing a stake of 7,855 shares — an estimated $44K sold.

State Board of Administration of Florida Retirement System first reported a position in OREX in Q2 2013 and held it in 12 quarters. The position peaked at $615K in Q1 2015. 73 funds tracked by Wall St. Rank hold OREX as of Q2 2016.

  • State Board of Administration of Florida Retirement System reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 7,855 Orexigen Therapeutics, Inc. shares in Q2 2016, an estimated $44K.
  • State Board of Administration of Florida Retirement System first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 12 quarters.
  • State Board of Administration of Florida Retirement System's Orexigen Therapeutics, Inc. position peaked at $615K in Q1 2015.
  • 73 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2016.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2016, filed 4 Aug 2016.